Current filters:


Popular Filters

6801 to 6825 of 7182 results

Bayer still aims for top-10 position in Pharma


Germany's Bayer (BAY: DE) is still confident that it can become a top-10 gobal pharmaceutical company,…

Markets & MarketingMergers & AcquisitionsPharmaceuticalResearch

Dainippon Sumitomo to acquire Boston Biomedical


Japanese drugmaker Dainippon Sumitomo Pharma (4506: JP) says it has reached an agreement for the acquisition…

BiotechnologyMergers & AcquisitionsOncologyPharmaceutical

Forest Labs, Gedeon Richter plan 2012 filing for cariprazine


Positive results from two phase III trials of Forest Laboratories and Gedeon Richter's new antipsychotic…

cariprazineForest LaboratoriesGedeon RichterHomeLexaproNamendaNeurologicalPharmaceutical

FDA expands on cholesterol-lowering drug risks


Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins…

AstraZenecaCardio-vascularCrestorLipitorMerck & CoNorth AmericaPfizerPharmaceuticalRegulationZocor

Bayer achieved its targets in 2011, posing 4.1% sales rise


Germany’s Bayer Group (BAY: DE) says it had a very successful year in 2011 both strategically and…


Lundbeck buys remaining rights to desmoteplase from Paion


Danish CNS drug specialist Lundbeck A/S (LUND: DC) and Germany’s Paion AG (FSE: PA8) have entered…

Cardio-vasculardesmoteplaseLundbeckMergers & AcquisitionsPaionPharmaceutical

Bayer and J&J’s Xarelto gets US Priority Review for new indication


The US Food and Drug Administration has granted Priority Review designation to the supplemental New Drug…

BayerCardio-vascularJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationXarelto

Slower growth in Swiss economy will impact pharma, says BMI


It is the view that the Swiss economy will record slower growth in 2012, says Business Monitor International…

EuropeMarkets & MarketingPharmaceutical

Merck warned for not carrying out post-approval sitagliptin study


The US Food and Drug Administration (FDA) has sent a warning letter to Merck & Co for failing to carry…

DiabetesJanumetJanuviaMerck & CoPharmaceuticalRegulationsitagliptinSitagliptin Metformin HCL

Roche extends Illumina takeover deadline


Roche has extended its $5.7 billion hostile takeover offer for genetic sequencing specialist Illumina…

HomeIlluminaMergers & AcquisitionsPharmaceuticalRoche

GSK inks $300m rare diseases alliance with Angiochem


GlaxoSmithKline has forged an R&D alliance with Montreal, Canada-based Angiochem that will focus on the…

AngiochemCerezymeGenzymeGSKNeurologicalPharmaceuticalRare diseasesShireVpriv

New data support efficacy of Astellas' mirabegron for overactive bladder


Astellas Pharma has reported the results of three separate clinical trials which further support the…

Astellas PharmaBetanisGenito-urinaryHomemirabegronPharmaceuticalVESIcare

Takeda's GPR40 agonist for diabetes promising in Ph II trial


A Phase II trial of Takeda's GPR40 agonist TAK-875 published in The Lancet has found that the drug is…

DiabetesHomepeginesatidePharmaceuticalTAK-875Takeda Pharmaceuticals

GSK boss accuses UK government of blocking new drugs to save money


The chief executive of the UK’s largest pharmaceutical company, GlaxoSmithKline (LSE: GSK) has accused…

EuropeGlaxoSmithKlineMarkets & MarketingPharmaceuticalPricingRegulation

Greek pharma sector bemoans accumulation of debts


The Greek pharmaceutical industry association, the SFEE, says that pharmaceutical companies may go out…


No proof of added benefit for GlaxoSmithKline’s Trobalt, says IQWiG


In another warning to drugmakers trying to get approval of new drugs under Germany’s AMNOG reform…


Forest Labs get EU appro for Colobreathe


US drugmaker Forest Laboratories (NYSE: FRX) said on Friday that the European Medicines Agency has approved…

ColoBreatheColomycinEuropeForest LaboratoriesPharmaceuticalRare diseasesRegulation

Daiichi Sankyo and Terumo link up for vaccine development


Drug major Daiichi Sankyo (TYO: 4568) and fellow Japanese company Terumo Corp (TYO: 4543) have entered…

Antibiotics and Infectious diseasesDaiichi SankyoPharmaceuticalResearchTerumoVaccines

Access Pharma’s MuGard OKed in China


USA-based specialist in supportive care for cancer patients Access Pharmaceuticals (OTCBB: ACCP) revealed…

Access PharmaceuticalsAsia-PacificJain An PharmaceuticalsMuGardOncologyPharmaceuticalRegulationRhei Pharmaceuticals

Merck KGaA sets out efficiency program, with cost and job cuts likely


Adding to the list of pharma companies announcing significant structural changes and job cuts, on Friday…

FinancialManagementMerck KGaAPharmaceutical

Quintiles to expand clinical development capabilities in Russia


Biopharmaceutical services company Quintiles is moving further into emerging markets, last week signing…

EuropePharmaceuticalQuintilesRegulationResearchRVC Biofund

Herborium signs Lol to be acquired by China Health Resource


New Jersey, USA-based botanical therapeutics company Herborium (Pink Sheets: HBRM) says it has signed…

China Health ResourceHerboriumMergers & AcquisitionsPharmaceutical

6801 to 6825 of 7182 results

Back to top